Intranasal Administration Of Foralumab Demonstrating Modulated Effector News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tiziana Announces Publication of a Peer-Reviewed Article on the Intranasal Administration of Foralumab Demonstrating Modulated Effector CD8+ T cell Function and an Induced T Cell Regulatory. | November 23, 2022

New yorkUnited statesWomens hospitalIrina kofflerMatthew davisHana malikIntranasal administration of foralumab demonstrating modulated effectorTiziana life sciencesLifesci advisorsTiziana life sciences ltdHarvard medical schoolBusiness developmentTiziana announces publicationPeer reviewed articleIntranasal administrationForalumab demonstrating modulated effector